Abbott (ABT) Posts Strong Q4 Earnings, But Investors Eye Light Revs, Outlook
Shares of Abbott Labs (NYSE: ABT) are trading slightly lower Wednesday following mixed fourth-quarter results and light guidance for 2012.
Revenue increased 4.1 percent from $9.97 billion during the same quarter last year to $10.38 billion. The Street was looking for revs of $10.63 billion.
Abbott's net income rose 13.3 percent to $2.295 billion, or $1.02 per share. Excluding certain one-time items, earnings popped to $1.45 per share. The Street was looking for EPS of $1.44.
Leading the sales charge was HUMIRA, which rose 15.9 percent to $2.178 billion. The most consolidation came from Kaletra, falling 15.6 percent to $288 million.
Cash flow was $9 billion in 2011.
Looking ahead, Abbott expects 2012 ongoing earnings of $4.95 to $5.05 per share, compared with Street views looking for $5.02 per share.
Abbott shares last traded at $55.03, down 1.7 percent from Tuesday's close.
Revenue increased 4.1 percent from $9.97 billion during the same quarter last year to $10.38 billion. The Street was looking for revs of $10.63 billion.
Abbott's net income rose 13.3 percent to $2.295 billion, or $1.02 per share. Excluding certain one-time items, earnings popped to $1.45 per share. The Street was looking for EPS of $1.44.
Leading the sales charge was HUMIRA, which rose 15.9 percent to $2.178 billion. The most consolidation came from Kaletra, falling 15.6 percent to $288 million.
Cash flow was $9 billion in 2011.
Looking ahead, Abbott expects 2012 ongoing earnings of $4.95 to $5.05 per share, compared with Street views looking for $5.02 per share.
Abbott shares last traded at $55.03, down 1.7 percent from Tuesday's close.